We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+6.87%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$2.76B
AUM Growth
+$132M
Cap. Flow
-$12.2M
Cap. Flow %
-0.44%
Top 10 Hldgs %
16.26%
Holding
440
New
32
Increased
174
Reduced
185
Closed
33

Top Buys

Rank Stock Value
1
CNK icon
Cinemark Holdings
CNK
+$7.16M
2
PPL
PPL Corp
PPL
+$6.93M
3
KDP icon
Keurig Dr Pepper
KDP
+$6.58M
4
ESI icon
Element Solutions
ESI
+$6.21M
5
XOM icon
ExxonMobil
XOM
+$5.88M

Sector Composition

Rank Sector Weight
1 Technology 22.03%
2 Financials 13.32%
3 Healthcare 13.15%
4 Industrials 12.09%
5 Consumer Discretionary 10.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOD icon
326
Modine Manufacturing
MOD
$10.4B
$1.24M 0.04%
37,570
+8,149
+28% +$203K
SNV
327
DELISTED
Synovus
SNV
$1.23M 0.04%
40,825
-2,568
-6% -$75.1K
VVV icon
328
Valvoline
VVV
$4.51B
$1.21M 0.04%
32,374
-30,262
-48% -$1.1M
AZEK
329
DELISTED
The AZEK Co
AZEK
$1.2M 0.04%
+39,754
New +$1.03M
WH icon
330
Wyndham Hotels & Resorts
WH
$5.48B
$1.19M 0.04%
17,390
+841
+5% +$57.4K
CDNS icon
331
Cadence Design Systems
CDNS
$93.4B
$1.19M 0.04%
5,070
-183
-3% -$39.8K
VTS icon
332
Vitesse Energy
VTS
$665M
$1.18M 0.04%
52,734
-8,329
-14% -$174K
CALX icon
333
Calix
CALX
$2.39B
$1.18M 0.04%
23,620
-19,409
-45% -$936K
ALNY icon
334
Alnylam Pharmaceuticals
ALNY
$29.3B
$1.17M 0.04%
6,174
-4
-0.1% -$793
ARRY icon
335
Array Technologies
ARRY
$855M
$1.16M 0.04%
51,539
+2,498
+5% +$53.5K
GLOB icon
336
Globant
GLOB
$1.61B
$1.15M 0.04%
+6,391
New +$1.05M
DEN
337
DELISTED
Denbury Inc.
DEN
$1.14M 0.04%
13,257
+4,438
+50% +$402K
LNG icon
338
Cheniere Energy
LNG
$52.9B
$1.12M 0.04%
7,372
-263
-3% -$38.9K
NEO icon
339
NeoGenomics
NEO
$2.13B
$1.06M 0.04%
66,010
-17,087
-21% -$282K
ICFI icon
340
ICF International
ICFI
$1.72B
$1.06M 0.04%
8,510
+412
+5% +$47.5K
SUPN icon
341
Supernus Pharmaceuticals
SUPN
$2.77B
$1.06M 0.04%
+35,139
New +$1.23M
HQY icon
342
HealthEquity
HQY
$8.75B
$1.04M 0.04%
16,478
+801
+5% +$46.4K
ROIV icon
343
Roivant Sciences
ROIV
$26.2B
$1.04M 0.04%
102,783
+54,997
+115% +$492K
WTFC icon
344
Wintrust Financial
WTFC
$10.7B
$1.03M 0.04%
14,115
+6,481
+85% +$442K
VKTX icon
345
Viking Therapeutics
VKTX
$4B
$1M 0.04%
61,819
+10,491
+20% +$220K
ARGX icon
346
argenx
ARGX
$54.1B
$999K 0.04%
2,563
-91
-3% -$35.8K
NOG icon
347
Northern Oil and Gas
NOG
$2.35B
$969K 0.04%
28,245
+1,368
+5% +$44.3K
HOLX
348
DELISTED
Hologic
HOLX
$955K 0.03%
11,800
-437
-4% -$35.7K
VRDN icon
349
Viridian Therapeutics
VRDN
$2.67B
$942K 0.03%
39,600
+6,001
+18% +$154K
ZS icon
350
Zscaler
ZS
$27.3B
$933K 0.03%
+6,378
New +$779K

Similar funds

Chartwell Investment Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Chartwell Investment Partners held 440 positions worth $2.76B, up 5% from $2.63B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Chartwell Investment Partners's Q2 2023 filing shows 32 new, 174 increased, 185 reduced and 33 closed positions. Its largest new stake was Keurig Dr Pepper: 200,604 shares worth $6.27M. The largest sale was NVIDIA, an estimated $11.1M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Chartwell Investment Partners's largest Q2 2023 buy was Keurig Dr Pepper: 200,604 shares worth $6.27M.
  • Chartwell Investment Partners added most to Cinemark Holdings in Q2 2023, an estimated $7.16M increase.
  • Chartwell Investment Partners's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $11.1M.
  • Chartwell Investment Partners fully exited McGrath RentCorp in Q2 2023, selling an estimated $9.28M.
  • Chartwell Investment Partners's ten largest holdings make up 16% of its $2.76B portfolio in Q2 2023.
  • Chartwell Investment Partners opened 32 new positions and closed 33 in Q2 2023.
  • Chartwell Investment Partners's portfolio value rose 5% quarter-over-quarter to $2.76B.

Based on Chartwell Investment Partners's 13F filing for Q2 2023, filed 25 Jul 2023.